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Carotid artery stenting is safe and associated with
comparable outcomes in men and womenEndovascular treatment of extracranial carotid bifurca-
tion occlusive disease has increased over the last five years.
The authors review outcomes of carotid artery stenting
(CAS) based on gender and conclude that the technique is
safe and has equivalent outcomes in women and men.
The procedure is described in the Current Procedural
Terminology (CPT) manual based on the use of embolic
protection. There are twoCategory I CPT codes, created in
2005 (despite no Food and Drug Administration (FDA)
approval at that time): carotid stent with embolic protec-
tion (CPT code 37215) and carotid stent without embolic
protection (CPT code 37216). These bundled descriptors
include 90-day global services, include all selective cathe-
terization, include pre-stent angioplasty, include post-stent
angioplasty, and include all radiology supervision and in-
terpretation except at the great vessel origins. The CAS
code is reported once regardless of the number of stents
implanted. However, diagnostic catheterization and imag-
ing on the opposite side or within the vertebral arteries is
separately reportable. Also, CPT code 75650 (aortic arch
angiography including the great vessel origins) was origi-
nally excluded in 2005 through National Correct Coding
Initiative edits but the edit was deleted in Version 13.3 on
October 1, 2007. CPT code 37215 has 30.19 total and
19.58 work relative value units (RVUs) in 2008. CPT code
37216 has 27.18 total and 18.85 work RVUs in 2008 but
this code is currently not valued (reimbursed) in the Medi-
care Physicians Fee Schedule, which mandates the use of a
protection device for reimbursement.
CAS for non-research patients has strict coverage limi-
tations. There is a March 15, 2005, Center for Medicare
and Medicaid Services (CMS) Coverage Memo, which
approves reimbursement only if a patient has all of the four
requirements: lateralizing transient ischemic attack or mi-
nor stroke (Rankin score 3), “high risk” for carotid
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giography, and use of an embolic protection device. That
implies that if a carotid stent is planned but the embolic
protection device cannot be advanced appropriately, the
procedure, according to CMS guidelines, should be
aborted and consideration for open endarterectomy be
discussed. Private insurers, for the most part, have followed
CMS’s lead.
Additionally, CMS requires facility accreditation. To
comply, each hospital must certify that it possesses an
adequate imaging and equipment inventory, maintains ap-
propriate consult support services, oversees a provider cre-
dentialing venue, ensures a data collection mechanism, and
manages an internal analysis of outcomes at an interval less
than every six months. The provider must also report his or
her outcomes at least every two years including any patient
treated outside of the coverage criteria on a FDA-approved
trial.
In 2007, the vendors who manufacture the CAS plat-
forms requested a national coverage decision (NCD) re-
consideration and CMS responded initially by proposing:
cover asymptomatic high surgical-risk patients with 80%
angiographically confirmed stenosis, exclude patients with
age greater than 80, and mandated pre-operative surgical
consultation. After the required public comments period,
the final CMS decision on April 30, 2007, cancelled all of
the above proposed revisions, and reverted to 2005 cover-
age determination.
In 2008, four professional societies requested a formal
CMS reconsideration for coverage of: asymptomatic “ana-
tomic high surgical risk” patients with 80% angiographi-
cally confirmed stenosis as well as symptomatic “anatomic
high surgical risk” patients with 50-69% angiographically
confirmed stenosis. CMS initially proposed no change
in the 2005 CASNCD after receiving the application. After
the comment period ended, CMS finalized no changes in
the NCD for percutaneous transluminal angioplasty of the
carotid artery concurrent with stenting (Medicare NCD
Manual 20.7) and published this response on October 14,
2008.
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